Eupraxia Pharmaceuticals reported net income of -$14.49M for the quarter ended Jun 2026. This income statement covers 15 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 21.59M | 27.28M | 35.64M | 39.96M | |||||||||||
| Operating items | |||||||||||||||
| Research & DevelopmentR&D | 2.27M | 3.79M | 4.76M | 9.54M | 4.18M | 3.97M | 4.05M | 3.88M | 3.85M | 5.20M | 4.42M | 7.87M | 11.17M | 12.81M | |
| Wages, Salaries and OtherWages | 1.39M | 1.46M | 1.42M | 1.66M | 1.71M | 1.79M | 3.10M | 4.13M | |||||||
| Selling, General & AdministrativeSG&A | 1.26M | 1.92M | 1.86M | 2.44M | 2.52M | 2.58M | 2.22M | 3.60M | 3.27M | 3.07M | 2.47M | 8.30M | 4.78M | 5.30M | |
| Restructuring CostsRestructuring | 1.84M | 1.12M | 1.42M | 1.44M | 1.59M | 1.49M | 1.94M | 2.43M | |||||||
| Other Operating ExpensesOther Opex | -0.31M | -3.65M | 1.88M | 1.25M | 0.77M | 0.43M | -0.00M | 0.00M | -1.94M | -0.00M | |||||
| Operating ExpensesOpex | 3.54M | 5.71M | 6.62M | 11.98M | 6.69M | 6.56M | 6.27M | 7.48M | 7.12M | 8.26M | 6.88M | 16.16M | 15.96M | 18.10M | |
| EBIT | -4.25M | -9.81M | -6.47M | -6.35M | -5.99M | -7.53M | -6.76M | -8.74M | -6.37M | -16.71M | -12.64M | -14.46M | |||
| Non-operating items | |||||||||||||||
| Non Operating Interest Expenses | -0.29M | -0.30M | -0.32M | -0.26M | -0.32M | -0.28M | -451.00 | -137.00 | |||||||
| Interest & Investment IncomeInt & Inv Inc | 0.16M | 0.15M | 0.19M | 0.35M | 0.24M | 0.40M | 0.30M | 0.22M | 0.31M | 0.26M | 0.18M | 0.67M | 1.07M | 1.39M | |
| Other Non Operating IncomeOther Non Op Inc. | 0.02M | 0.01M | -0.03M | 0.06M | -0.14M | -0.08M | 0.12M | -0.07M | 0.05M | -0.73M | -0.51M | -2.43M | 2.24M | 2.25M | |
| Non Operating IncomeNon Op. Inc. | -0.42M | -3.80M | 1.73M | 1.41M | 0.54M | 0.49M | 0.28M | -0.05M | 0.36M | -0.48M | 0.51M | -0.55M | 3.32M | 3.64M | |
| Net income details | |||||||||||||||
| EBT | -3.96M | -9.51M | -6.15M | -6.07M | -5.99M | -7.53M | -6.76M | -8.74M | -6.37M | -16.71M | -12.64M | -14.46M | |||
| Tax ProvisionsTaxes | -0.01M | 0.01M | -0.00M | -0.01M | -0.01M | -0.03M | |||||||||
| Profit After TaxPAT | -3.96M | -9.51M | -4.90M | -10.61M | -6.16M | -6.06M | -5.99M | -7.53M | -6.77M | -8.75M | -6.37M | -16.72M | -12.65M | -14.49M | |
| Income from Non-Controlling InterestsInc. Minority | -0.06M | -0.13M | -0.17M | -0.38M | -0.11M | -0.06M | -0.05M | -0.02M | -0.00M | -0.01M | -0.01M | -0.01M | -0.00M | -0.01M | |
| Income from Continuing OperationsIncome (Continuing) | -3.96M | -9.51M | -6.15M | -6.07M | -5.99M | -7.53M | -6.76M | -8.74M | -6.37M | -16.71M | -12.63M | -14.43M | |||
| Consolidated Net IncomeConsol Net Inc. | -3.96M | -9.51M | -6.15M | -6.07M | -5.99M | -7.53M | -6.76M | -8.74M | -6.37M | -16.71M | -12.63M | -14.43M | |||
| Income towards Parent CompanyParent Net Inc | -3.90M | -9.38M | -4.72M | -10.23M | -6.04M | -6.01M | -5.94M | -7.51M | -6.76M | -8.74M | -6.36M | -16.71M | -12.65M | -14.49M | |
| Net Income towards Common StockholdersNet Income | -3.90M | -9.38M | -4.72M | -10.23M | -6.04M | -6.01M | -5.94M | -7.51M | -6.76M | -8.74M | -6.36M | -16.71M | -12.65M | -14.49M | |
| Additional items | |||||||||||||||
| EPS (Basic) | -0.20 | -0.49 | -0.24 | -0.42 | -0.25 | -0.25 | -0.25 | -0.22 | -0.20 | -0.26 | -0.19 | -0.42 | -0.32 | -0.36 | |
| EPS (Diluted) | -0.20 | -0.49 | -0.24 | -0.42 | -0.25 | -0.25 | -0.25 | -0.22 | -0.20 | -0.26 | -0.19 | -0.42 | -0.32 | -0.36 | |
| Shares Outstanding | 19.29M | 19.29M | 19.29M | 19.29M | 24.15M | 24.15M | 24.15M | 24.15M | 33.93M | 33.93M | 33.93M | 33.93M | 39.96M | 39.96M | 39.96M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 19.29M | 19.29M | 19.29M | 19.29M | 24.15M | 24.15M | 24.15M | 24.15M | 33.93M | 33.93M | 33.93M | 33.93M | 39.96M | 39.96M | 39.96M |
| EBITDA | -4.25M | -9.81M | -6.47M | -6.35M | -5.99M | -7.53M | -6.76M | -8.74M | -6.37M | -16.71M | -12.64M | -14.46M | |||
| Interest ExpensesInt Expense | -0.29M | -0.30M | -0.32M | -0.26M | -0.32M | -0.28M | -451.00 | -137.00 | |||||||
| Tax Rate | 0.08 | -0.08 | 0.04 | 0.06 | 0.11 | 0.21 |